EichorEICHOR
Condition: Any Solid Tumor Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Any Solid Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Phase 1 · 1 location(s) · Plus Therapeutics · NCT07098806
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
Phase 2 · 10 location(s) · Memorial Sloan Kettering Cancer Center · NCT04165772
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1/Phase 2 · 15 location(s) · VM Oncology, LLC · NCT03556228
AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Avelos Therapeutics Inc. · NCT06911333
A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 · 3 location(s) · ABL Bio, Inc. · NCT06126666
High Definition Medicine for Solid Tumors Oncology
Phase N/A · 9 location(s) · Centro Nacional de Investigaciones Oncologicas CARLOS III · NCT06590506
Is the 1939 Cancer Act Fit for Purpose in the Modern Technology Era?
Phase N/A · 1 location(s) · Royal Cornwall Hospitals Trust · NCT07584824
WellSpan-THRIVE Cancer QOL Study
Phase N/A · 5 location(s) · WellSpan Health · NCT07433660
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and
Phase 1 · 8 location(s) · ABL Bio, Inc. · NCT04762641
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →